Pharmacokinetic effect of aprepitant on irinotecan in patients with colorectal cancer

被引：0
|
作者：
Nieva, J. J.
Webb, W.
Siuzdak, G.
机构：
[1] Scripps Canc Ctr, La Jolla, CA USA
[2] Scripps Res Inst, La Jolla, CA 92037 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19622
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer
    Murren, JR
    Peccerillo, K
    DiStasio, SA
    Li, X
    Leffert, JJ
    Pizzorno, G
    Burtness, BA
    McKeon, A
    Cheng, YC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (01) : 43 - 50
  • [42] The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients
    Walko, Christine M.
    Combest, Austin J.
    Spasojevic, Ivan
    Yu, Angela Y. C.
    Bhushan, Shriya
    Hull, J. Heyward
    Hoskins, Janelle
    Armstrong, Delma
    Carey, Lisa
    Collicio, Frances
    Dees, E. Claire
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1189 - 1196
  • [43] Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer
    John R. Murren
    Kathleen Peccerillo
    Susan A. DiStasio
    Xin Li
    Janine J. Leffert
    Giuseppe Pizzorno
    Barbara A. Burtness
    Anne McKeon
    Yung chi Cheng
    Cancer Chemotherapy and Pharmacology, 2000, 46 : 43 - 50
  • [44] The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients
    Christine M. Walko
    Austin J. Combest
    Ivan Spasojevic
    Angela Y. C. Yu
    Shriya Bhushan
    J. Heyward Hull
    Janelle Hoskins
    Delma Armstrong
    Lisa Carey
    Frances Collicio
    E. Claire Dees
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1189 - 1196
  • [45] Effect of S-1 on pharmacokinetics of irinotecan in a patient with colorectal cancer
    Yokoo, Koji
    Watanabe, Hiroshi
    Hamada, Akinobu
    Masa, Kengo
    Saito, Hideyuki
    Terazaki, Hisayasu
    Sasaki, Yutaka
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (04) : 422 - 424
  • [46] Developing a genotoxic predictive test of irinotecan effect in metastatic colorectal cancer
    Wood, Joanna P.
    Bowman, Karen
    Thomas, Anne L.
    Jones, George D. D.
    MUTAGENESIS, 2012, 27 (01) : 136 - 136
  • [47] Irinotecan - Effective alternative in colorectal cancer
    不详
    STRAHLENTHERAPIE UND ONKOLOGIE, 2000, 176 (12) : A4 - A4
  • [48] A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense™, G3139) and irinotecan in patients with metastatic colorectal cancer
    Mita, MM
    Ochoa, L
    Rowinsky, EK
    Kuhn, J
    Schwartz, G
    Hammond, LA
    Patnaik, A
    Yeh, IT
    Izbicka, E
    Berg, K
    Tolcher, AW
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 313 - 321
  • [49] Irinotecan for the treatment of metastatic colorectal cancer
    Assenat, Eric
    Duffour, Jacqueline
    Ychou, Marc
    BULLETIN DU CANCER, 2006, 93 (05) : 507 - 515
  • [50] Optimizing irinotecan regimens for colorectal cancer
    Yim, Kein-Leong
    Cunningham, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (10) : 560 - 561
12345